18. Spinocerebellar degeneration Clinical trials / Disease details


Clinical trials : 76 Drugs : 98 - (DrugBank : 31) / Drug target genes : 44 - Drug target pathways : 65

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04817111
(ClinicalTrials.gov)
May 17, 202110/3/2021NAD+ Precursor Supplementation in Friedreich's AtaxiaA Phase 2a Study of NAD+ Precursor Supplementation in Friedreich's AtaxiaFriedreich AtaxiaDrug: MIB-626Metro International Biotech, LLCChildren's Hospital of PhiladelphiaActive, not recruiting18 Years64 YearsAll10Phase 2United States